Orthofix Medical Inc. (OFIX)
Every FINRA and SEC series the site collects for Orthofix Medical Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
2.4M
Short interest
settlement 2026-08-31
9.2
Days to cover
+14.5% vs prior
58.2%
Short share of volume
2026-09-17
213
Fails to deliver
settlement 2026-08-26
Tue 3 Nov
Next earnings
estimated; last year 2025-11-04
-$417K
Insider flow, 90 days
0 buys, 4 sells
As of 2026-09-17.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in OFIX is 2,375,736 shares, up 252,320 shares over the last month. Over the last 48 readings it ranged from 609,706 shares (28 February 2025) to 2,931,376 shares (13 September 2024). At the reported average volume of 258K shares a day that is 9.2 days to cover, elevated.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/ofix" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 2,375,736 | +14.5% | 258,107 | 9.20 |
| 2026-08-14 | 2,074,158 | -2.3% | 477,867 | 4.34 |
| 2026-07-31 | 2,123,416 | -15.4% | 286,081 | 7.42 |
| 2026-07-15 | 2,510,464 | +6.2% | 404,965 | 6.20 |
| 2026-06-30 | 2,363,876 | +18.5% | 433,261 | 5.46 |
| 2026-06-15 | 1,994,948 | +2.3% | 426,341 | 4.68 |
| 2026-05-29 | 1,950,321 | +50.5% | 638,773 | 3.05 |
| 2026-05-15 | 1,295,954 | +4.7% | 379,395 | 3.42 |
| 2026-04-30 | 1,237,366 | -7.4% | 212,266 | 5.83 |
| 2026-04-15 | 1,336,557 | +11.5% | 247,164 | 5.41 |
| 2026-03-31 | 1,198,336 | +11.5% | 281,159 | 4.26 |
| 2026-03-13 | 1,075,068 | -2.3% | 308,145 | 3.49 |
| 2026-02-27 | 1,100,792 | +4.8% | 290,476 | 3.79 |
| 2026-02-13 | 1,050,127 | +4.2% | 223,594 | 4.70 |
| 2026-01-30 | 1,007,739 | -5.5% | 202,307 | 4.98 |
| 2026-01-15 | 1,066,702 | +5.4% | 224,277 | 4.76 |
| 2025-12-31 | 1,012,198 | -11.3% | 192,271 | 5.26 |
| 2025-12-15 | 1,141,692 | -12.2% | 182,982 | 6.24 |
| 2025-11-28 | 1,299,978 | -13.5% | 258,817 | 5.02 |
| 2025-11-14 | 1,503,304 | -3.4% | 287,229 | 5.23 |
| 2025-10-31 | 1,555,974 | -4.8% | 224,132 | 6.94 |
| 2025-10-15 | 1,635,275 | -5.9% | 252,337 | 6.48 |
| 2025-09-30 | 1,737,377 | +3.7% | 289,310 | 6.01 |
| 2025-09-15 | 1,675,356 | -7.8% | 389,068 | 4.31 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 17 September 2026, the short share of OFIX volume is 58.2%, down 1.8 points over the last five sessions. Over the last 52 readings it ranged from 30.9% (28 August 2026) to 81.9% (20 July 2026). The latest reading is 3.9 points above the 30-session average of 54.3%, on 66K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-17 | 39K | 66K | 58.2% | 10 |
| 2026-09-16 | 37K | 75K | 49.5% | 0 |
| 2026-09-15 | 45K | 92K | 48.7% | 0 |
| 2026-09-14 | 56K | 83K | 67.8% | 0 |
| 2026-09-11 | 86K | 156K | 55.0% | 0 |
| 2026-09-10 | 58K | 97K | 60.1% | 0 |
| 2026-09-09 | 105K | 193K | 54.1% | 0 |
| 2026-09-08 | 59K | 94K | 62.3% | 0 |
| 2026-09-04 | 38K | 66K | 57.1% | 0 |
| 2026-09-03 | 56K | 103K | 54.2% | 0 |
| 2026-09-02 | 67K | 101K | 65.7% | 336 |
| 2026-09-01 | 62K | 125K | 49.9% | 0 |
| 2026-08-31 | 78K | 126K | 61.8% | 0 |
| 2026-08-28 | 25K | 80K | 30.9% | 0 |
| 2026-08-27 | 20K | 54K | 36.8% | 0 |
| 2026-08-26 | 43K | 74K | 58.1% | 0 |
| 2026-08-25 | 46K | 87K | 53.0% | 0 |
| 2026-08-24 | 61K | 110K | 55.6% | 0 |
| 2026-08-21 | 100K | 148K | 67.7% | 0 |
| 2026-08-20 | 47K | 78K | 59.6% | 0 |
| 2026-08-19 | 30K | 62K | 49.4% | 0 |
| 2026-08-18 | 24K | 61K | 38.7% | 0 |
| 2026-08-17 | 50K | 77K | 65.5% | 0 |
| 2026-08-14 | 45K | 93K | 48.8% | 0 |
| 2026-08-13 | 31K | 67K | 46.2% | 0 |
| 2026-08-12 | 55K | 87K | 63.2% | 0 |
| 2026-08-11 | 52K | 151K | 34.6% | 1,500 |
| 2026-08-10 | 62K | 117K | 53.1% | 0 |
| 2026-08-07 | 75K | 130K | 57.7% | 0 |
| 2026-08-06 | 86K | 130K | 66.4% | 730 |
Fails to deliver
SEC, by settlement date. JSONAs of 26 August 2026, the fails-to-deliver balance in OFIX is 213 shares, up 13 shares over the last settlement date. Over the last 52 readings it ranged from 1 share (9 June 2026) to 10,168 shares (14 October 2025). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-26 | 213 | $9.64 | $2K |
| 2026-08-18 | 200 | $10.03 | $2K |
| 2026-08-14 | 138 | $10.18 | $1K |
| 2026-08-07 | 6,330 | $10.60 | $67K |
| 2026-08-06 | 633 | $10.42 | $7K |
| 2026-08-04 | 8,991 | $12.26 | $110K |
| 2026-07-31 | 98 | $11.79 | $1K |
| 2026-07-30 | 110 | $12.17 | $1K |
| 2026-07-29 | 216 | $12.26 | $3K |
| 2026-07-27 | 330 | $11.25 | $4K |
| 2026-07-22 | 92 | $11.63 | $1K |
| 2026-07-21 | 3,291 | $11.56 | $38K |
| 2026-07-16 | 283 | $11.29 | $3K |
| 2026-06-17 | 238 | $9.41 | $2K |
| 2026-06-16 | 922 | $9.20 | $8K |
| 2026-06-15 | 2,099 | $9.31 | $20K |
| 2026-06-11 | 293 | $9.73 | $3K |
| 2026-06-09 | 1 | $9.69 | $10 |
| 2026-06-05 | 221 | $10.34 | $2K |
| 2026-06-02 | 96 | $9.27 | $890 |
| 2026-05-13 | 50 | $12.18 | $609 |
| 2026-03-31 | 775 | $11.32 | $9K |
| 2026-03-25 | 1,055 | $11.72 | $12K |
| 2026-03-12 | 67 | $12.27 | $822 |
| 2026-03-10 | 537 | $12.46 | $7K |
| 2026-03-09 | 4 | $12.62 | $50 |
| 2026-03-06 | 106 | $12.57 | $1K |
| 2026-03-02 | 131 | $13.53 | $2K |
| 2026-02-13 | 393 | $13.27 | $5K |
| 2026-02-03 | 289 | $13.45 | $4K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at OFIX reported 4 open-market sells worth $417K in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Fisher Patrick (President, Global Limb Recon) on 2026-09-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Fisher Patrick | President, Global Limb Recon | Sell | 150 | $9.39 | $1K | 51K |
| 2026-08-18 | Fisher Patrick | President, Global Limb Recon | Sell | 1K | $10.09 | $13K | 51K |
| 2026-08-17 | Juniper Investment Company, LLC | n/a | Sell | 20K | $10.01 | $200K | 85K |
| 2026-08-14 | Juniper Investment Company, LLC | n/a | Sell | 20K | $10.38 | $202K | 65K |
| 2026-06-18 | McPherron Aviva | Pres, Global Ops & Qual | Sell | 4K | $9.38 | $34K | 66K |
| 2026-06-10 | Paolucci Michael E | Director | Grant | 15K | $0.00 | $0 | 103K |
| 2026-06-10 | Maniar Shweta | Director | Grant | 15K | $0.00 | $0 | 69K |
| 2026-06-10 | BURRIS WAYNE | Director | Grant | 15K | $0.00 | $0 | 66K |
| 2026-06-10 | HENNEMAN JOHN B III | Director | Grant | 15K | $0.00 | $0 | 106K |
| 2026-06-10 | CAPPS VICKIE L | Director | Grant | 15K | $0.00 | $0 | 43K |
| 2026-06-10 | Finegan Michael | Director | Grant | 21K | $0.00 | $0 | 82K |
| 2026-06-10 | Hannon Jason | Director | Grant | 15K | $0.00 | $0 | 88K |
| 2026-06-10 | Kummeth Charles R. | Director | Grant | 15K | $0.00 | $0 | 76K |
| 2026-06-10 | Bazaar Alan Lee | Director | Grant | 15K | $0.00 | $0 | 65K |
| 2026-05-22 | Juniper Investment Company, LLC | n/a | Sell | 242K | $10.70 | $2.6M | 3.5M |
| 2026-05-07 | Engine Jet Capital, L.P. | TenPercentOwner | Buy | 18K | $12.20 | $222K | 3.8M |
| 2026-05-07 | Engine Jet Capital, L.P. | TenPercentOwner | Buy | 9K | $12.15 | $111K | 3.8M |
| 2026-05-07 | Engine Jet Capital, L.P. | TenPercentOwner | Buy | 2K | $12.20 | $22K | 382K |
| 2026-05-07 | Engine Jet Capital, L.P. | TenPercentOwner | Buy | 904 | $12.15 | $11K | 382K |
| 2026-05-07 | Engine Capital Management, LP | n/a | Buy | 904 | $12.15 | $11K | 382K |
| 2026-05-07 | Engine Capital Management, LP | n/a | Buy | 2K | $12.20 | $22K | 382K |
| 2026-05-07 | Engine Capital Management, LP | n/a | Buy | 9K | $12.15 | $110K | 3.8M |
| 2026-05-07 | Engine Capital Management, LP | n/a | Buy | 18K | $12.20 | $222K | 3.8M |
| 2026-05-07 | HENNEMAN JOHN B III | n/a | Buy | 5K | $12.26 | $61K | 91K |
| 2026-05-06 | Engine Jet Capital, L.P. | TenPercentOwner | Buy | 4K | $12.23 | $46K | 380K |
| 2026-05-06 | Engine Jet Capital, L.P. | TenPercentOwner | Buy | 38K | $12.23 | $467K | 3.8M |
| 2026-05-06 | Engine Capital Management, LP | n/a | Buy | 4K | $12.23 | $46K | 380K |
| 2026-05-06 | Engine Capital Management, LP | n/a | Buy | 38K | $12.23 | $467K | 3.8M |
| 2026-05-05 | Engine Jet Capital, L.P. | TenPercentOwner | Buy | 3K | $11.99 | $35K | 376K |
| 2026-05-05 | Engine Jet Capital, L.P. | TenPercentOwner | Buy | 110K | $11.99 | $1.3M | 3.8M |
| 2026-05-05 | Engine Capital Management, LP | n/a | Buy | 3K | $11.99 | $35K | 376K |
| 2026-05-05 | Engine Capital Management, LP | n/a | Buy | 110K | $11.99 | $1.3M | 3.8M |
| 2026-04-16 | Cedron Jorge Andres | CLO | Sell | 4K | $12.82 | $48K | 59K |
| 2026-03-17 | Vitale Lucas | CP&BOO | Sell | 4K | $11.92 | $51K | 160K |
| 2026-03-10 | CAPPS VICKIE L | n/a | Buy | 2K | $12.45 | $30K | 28K |
| 2026-03-10 | CAPPS VICKIE L | n/a | Buy | 100 | $12.44 | $1K | 25K |
| 2026-03-09 | CAPPS VICKIE L | n/a | Buy | 3K | $12.48 | $31K | 25K |
| 2026-03-05 | Vitale Lucas | CP&BOO | Sell | 1K | $12.55 | $14K | 165K |
| 2026-03-05 | REINHARDT MAX | President, Global Spine | Sell | 1K | $12.55 | $13K | 25K |
| 2026-03-05 | McPherron Aviva | Pres, Global Ops & Qual | Sell | 1K | $12.55 | $16K | 68K |
| 2026-03-05 | Fisher Patrick | President, Global Limb Recon | Sell | 758 | $12.55 | $10K | 51K |
| 2026-03-05 | Cedron Jorge Andres | CLO | Sell | 1K | $12.55 | $17K | 63K |
| 2026-03-05 | Calafiore Massimo | President & CEO | Sell | 6K | $12.55 | $76K | 320K |
| 2026-03-05 | Andrews Julie | CFO | Sell | 2K | $12.55 | $30K | 89K |
| 2026-03-04 | Vitale Lucas | CP&BOO | Sell | 1K | $12.92 | $15K | 166K |
| 2026-03-04 | REINHARDT MAX | President, Global Spine | Sell | 1K | $12.92 | $14K | 26K |
| 2026-03-04 | McPherron Aviva | Pres, Global Ops & Qual | Sell | 1K | $12.92 | $17K | 69K |
| 2026-03-04 | Fisher Patrick | President, Global Limb Recon | Sell | 778 | $12.92 | $10K | 51K |
| 2026-03-04 | Cedron Jorge Andres | CLO | Sell | 1K | $12.92 | $18K | 64K |
| 2026-03-04 | Calafiore Massimo | President & CEO | Sell | 6K | $12.92 | $80K | 326K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for OFIX worth $4K at the prices reported; 1 in the last 90 days worth $4K. Latest: PATRICK FISHER filed on 2026-09-01 to sell 450 shares ($4K) from 2026-09-01.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-01 | PATRICK FISHEROfficer | 450 | $4K | 0.001% | 2026-09-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON12 holders above 5% have filed on OFIX, 9 on Schedule 13D (active intent). The largest reported stake is John A. Bartholdson at 11.0% of the class (4,442,543 shares), filed 2026-05-27 for an event on 2026-05-22.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 8 | Armistice Capital, LLCinvestment adviser, other entity | 3.3M | 8.0% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 8 | Steven Boydparent holding company, individual | 3.3M | 8.0% | 2026-06-30 |
| 2026-05-27 | 13D/Ano. 5 | John A. Bartholdsonindividual | 4.4M | 11.0% | 2026-05-22 |
| 2026-05-27 | 13D/Ano. 5 | Alexis P. Michasindividual | 4.4M | 11.0% | 2026-05-22 |
| 2026-05-27 | 13D/Ano. 5 | Juniper Investment Company, LLCinvestment adviser | 4.4M | 11.0% | 2026-05-22 |
| 2026-05-27 | 13D/Ano. 5 | Juniper HF Investors II, LLCpartnership | 3.5M | 8.6% | 2026-05-22 |
| 2026-05-27 | 13D/Ano. 5 | Juniper Targeted Opportunity Fund, L.P.partnership | 3.5M | 8.6% | 2026-05-22 |
| 2026-05-27 | 13D/Ano. 5 | Juniper Targeted Opportunities, L.P.partnership | 936K | 2.3% | 2026-05-22 |
| 2026-05-27 | 13D/Ano. 5 | Juniper Targeted Opportunity Investors, LLCpartnership | 936K | 2.3% | 2026-05-22 |
| 2026-05-27 | 13D/Ano. 5 | Juniper Multi-Strategy Fund, L.P.partnership | 45K | 0.1% | 2026-05-22 |
| 2026-05-27 | 13D/Ano. 5 | Juniper HF Investors, LLCpartnership | 45K | 0.1% | 2026-05-22 |
| 2026-05-15 | 13G/Ano. 7 | Steven Boydparent holding company, individual | 2.7M | 6.7% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 7 | Armistice Capital, LLCinvestment adviser, other entity | 2.7M | 6.7% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 7 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-17 | 13G/Ano. 6 | Steven Boydparent holding company, individual | 2.6M | 6.7% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 6 | Armistice Capital, LLCinvestment adviser, other entity | 2.6M | 6.7% | 2025-12-31 |
| 2026-02-13 | 13D/Ano. 4 | John A. Bartholdsonindividual | 3.8M | 9.6% | 2026-02-11 |
| 2026-02-13 | 13D/Ano. 4 | Alexis P. Michasindividual | 3.8M | 9.6% | 2026-02-11 |
| 2026-02-13 | 13D/Ano. 4 | Juniper Investment Company, LLCinvestment adviser | 3.8M | 9.6% | 2026-02-11 |
| 2026-02-13 | 13D/Ano. 4 | Juniper Targeted Opportunity Fund, L.P.partnership | 2.8M | 7.1% | 2026-02-11 |
| 2026-02-13 | 13D/Ano. 4 | Juniper HF Investors II, LLCpartnership | 2.8M | 7.1% | 2026-02-11 |
| 2026-02-13 | 13D/Ano. 4 | Juniper Targeted Opportunities, L.P.partnership | 936K | 2.4% | 2026-02-11 |
| 2026-02-13 | 13D/Ano. 4 | Juniper Targeted Opportunity Investors, LLCpartnership | 936K | 2.4% | 2026-02-11 |
| 2026-02-13 | 13D/Ano. 4 | Juniper HF Investors, LLCpartnership | 45K | 0.1% | 2026-02-11 |
| 2026-02-13 | 13D/Ano. 4 | Juniper Multi-Strategy Fund, L.P.partnership | 45K | 0.1% | 2026-02-11 |
| 2025-11-14 | 13G/Ano. 5 | Armistice Capital, LLCinvestment adviser, other entity | 2.2M | 5.7% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 5 | Steven Boydparent holding company, individual | 2.2M | 5.7% | 2025-09-30 |
| 2025-10-21 | 13D/Ano. 3 | John A. Bartholdsonindividual | 3.2M | 8.2% | 2025-10-17 |
| 2025-10-21 | 13D/Ano. 3 | Alexis P. Michasindividual | 3.2M | 8.2% | 2025-10-17 |
| 2025-10-21 | 13D/Ano. 3 | Juniper Investment Company, LLCinvestment adviser | 3.2M | 8.2% | 2025-10-17 |
| 2025-10-21 | 13D/Ano. 3 | Juniper Targeted Opportunity Fund, L.P.partnership | 2.5M | 6.3% | 2025-10-17 |
| 2025-10-21 | 13D/Ano. 3 | Juniper HF Investors II, LLCpartnership | 2.5M | 6.3% | 2025-10-17 |
| 2025-10-21 | 13D/Ano. 3 | Juniper Targeted Opportunity Investors, LLCpartnership | 696K | 1.8% | 2025-10-17 |
| 2025-10-21 | 13D/Ano. 3 | Juniper Targeted Opportunities, L.P.partnership | 696K | 1.8% | 2025-10-17 |
| 2025-10-21 | 13D/Ano. 3 | Juniper HF Investors, LLCpartnership | 45K | 0.1% | 2025-10-17 |
| 2025-10-21 | 13D/Ano. 3 | Juniper Multi-Strategy Fund, L.P.partnership | 45K | 0.1% | 2025-10-17 |
| 2025-09-25 | 13D/Ano. 2 | John A. Bartholdsonindividual | 2.8M | 7.2% | 2025-09-23 |
| 2025-09-25 | 13D/Ano. 2 | Alexis P. Michasindividual | 2.8M | 7.2% | 2025-09-23 |
| 2025-09-25 | 13D/Ano. 2 | Juniper Investment Company, LLCinvestment adviser | 2.8M | 7.2% | 2025-09-23 |
| 2025-09-25 | 13D/Ano. 2 | Juniper HF Investors II, LLCpartnership | 2.4M | 6.1% | 2025-09-23 |
| 2025-09-25 | 13D/Ano. 2 | Juniper Targeted Opportunity Fund, L.P.partnership | 2.4M | 6.1% | 2025-09-23 |
| 2025-09-25 | 13D/Ano. 2 | Juniper Targeted Opportunity Investors, LLCpartnership | 407K | 1.0% | 2025-09-23 |
| 2025-09-25 | 13D/Ano. 2 | Juniper Targeted Opportunities, L.P.partnership | 407K | 1.0% | 2025-09-23 |
| 2025-09-25 | 13D/Ano. 2 | Juniper HF Investors, LLCpartnership | 45K | 0.1% | 2025-09-23 |
| 2025-09-25 | 13D/Ano. 2 | Juniper Multi-Strategy Fund, L.P.partnership | 45K | 0.1% | 2025-09-23 |
13F holders
Tracked managers holding OFIX at their latest 13F. JSON7 of the 30 tracked managers held OFIX at their latest 13F, $18.2M in total at quarter-end prices. AQR Capital Management is the largest at $8.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 887K | $8.1M | 0.00% | +698K |
| Millennium Management | 2026-06-30 | 862K | $7.9M | 0.00% | +701K |
| Renaissance Technologies | 2026-06-30 | 97K | $885K | 0.00% | -5K |
| Point72 Asset Management | 2026-06-30 | 73K | $667K | 0.00% | -86K |
| Citadel Advisors | 2026-06-30 | 49K | $452K | 0.00% | -77K |
| D. E. Shaw & Co. | 2026-06-30 | 11K | $104K | 0.00% | +850 |
| Two Sigma Investments | 2026-06-30 | 10K | $95K | 0.00% | -18K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) Orthofix Medical Inc. reported revenue of $210.9M, up 3.8% from the same quarter a year earlier, and net loss of $15.8M (-0.39 diluted EPS). In FY 2025 it generated $33.3M of operating cash flow. As of 2026-06-30, cash was $103.8M against $221.6M of debt.
- Cash
- $103.8M
- Debt
- $221.6M
- Equity
- $429.2M
- Total assets
- $873.0M
- Shares outstanding
- 40,732,608
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $210.9M | -$15.8M | -7.5% | -0.39 |
| Q1 2026 | 2026-03-31 | $196.7M | -$20.9M | -10.6% | -0.52 |
| Q4 2025derived | 2025-12-31 | $219.9M | n/a | n/a | n/a |
| Q3 2025 | 2025-09-30 | $205.6M | -$22.8M | -11.1% | -0.57 |
| Q2 2025 | 2025-06-30 | $203.1M | -$14.1M | -6.9% | -0.36 |
| Q1 2025 | 2025-03-31 | $193.6M | -$53.1M | -27.4% | -1.35 |
| Q4 2024derived | 2024-12-31 | $215.7M | n/a | n/a | n/a |
| Q3 2024 | 2024-09-30 | $196.6M | -$27.4M | -13.9% | -0.71 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $822.3M | n/a | $33.3M | n/a | n/a | n/a |
| FY 2024 | 2024-12-31 | $799.5M | n/a | $25.8M | n/a | n/a | n/a |
| FY 2023 | 2023-12-31 | $746.6M | n/a | -$45.8M | $60.3M | n/a | n/a |
| FY 2022 | 2022-12-31 | $460.7M | n/a | -$11.5M | $21.4M | n/a | n/a |
| FY 2021 | 2021-12-31 | $464.5M | n/a | $18.5M | $17.8M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
Orthofix Medical Inc. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows Orthofix Medical Inc. (OFIX), SEC CIK 884624, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-17.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-26.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-09-01.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 884624Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
- BSXBOSTON SCIENTIFIC CORP
- TNDMTANDEM DIABETES CARE INC
- DXCMDEXCOM INC
- PENPenumbra Inc
- SIBNSI-BONE, Inc.
- MMM3M CO
- LMATLEMAITRE VASCULAR INC
- INSPInspire Medical Systems, Inc.
- NVCRNovoCure Ltd
- RMDRESMED INC
- SYKSTRYKER CORP
- GKOSGLAUKOS Corp
- IRTCiRhythm Holdings, Inc.
- ICUIICU MEDICAL INC/DE
- ATECAlphatec Holdings, Inc.
- AORTARTIVION, INC.
- PODDINSULET CORP
- BDXBECTON DICKINSON & CO
- IRMDIRADIMED CORP
- ATRCAtriCure, Inc.
- UFPTUFP TECHNOLOGIES INC
- LUNGPulmonx Corp
- MMSIMERIT MEDICAL SYSTEMS INC
- ANGOANGIODYNAMICS INC
Datasets
Frequently Asked Questions
How much of OFIX is sold short?
What is OFIX's daily short volume?
Does OFIX have fails to deliver?
Are OFIX insiders buying or selling?
Have OFIX insiders filed to sell?
Who owns more than 5% of OFIX?
What did OFIX report last quarter?
Which funds hold OFIX?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.